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Abstract
Introduction: There are mixed reports on the incidence of intracranial haemorrhage in patients with dural arterio-
venous fistulas. We assessed new proposed risk factors (i.a. number of outflows and outflow diameter) of intracerebral 
haemorrhage due to intracranial dural arteriovenous fistula and presented our personal experience in endovascular 
treatment of dural arteriovenous fistulas.
Material and methods: The patient database from January 2006 and December 2016 was reviewed, and 25 patients with 
28 dural arteriovenous fistulas were identified. 
Results: 50% of patients presented with intracerebral haemorrhage. Multiple dural fistulas occurred in 12% of patients. 
Spearman’s rank correlation coefficient revealed that there was a strong association between Cognard classification 
type and time needed to treat (r = 0.59, p < 0.05), as well as the volume of contrast used (r = 0.77, p < 0.05). Infraten-
torial (r = 0.53, p < 0.05) and right-sided (r = 0.66, p < 0.05) localisation were more challenging to treat. Bleeding 
was associated with poorer clinical outcome (r = 0.48, p < 0.05). No significant differences were found between the 
non-haemorrhagic group and the haemorrhagic group regarding the number of outflows (p = 0.459) and largest 
outflow diameter (p = 0.298). Clinical evaluation at follow-up was as follows: 56% of patients were asymptomatic, 
24% had non-significant disability, maintaining independency, 16% had moderate disability, and 8% died – one in the 
course of intracerebral haemorrhage and one due to other sustained injuries. There were no reported embolisation- 
related complications.
Conclusions: To conclude, regardless of presentation, both symptomatic and asymptomatic dural arteriovenous fistulas 
deserve clinical attention, structured evaluation, and follow-up. Type I fistulas were associated with haemorrhage 
in 1/3 of all cases. Overall our results indicate that the risk of haemorrhage and dire consequences is multifactorial.
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Introduction
Intracranial dural arteriovenous fistula (dAVF) repre-
sents 10-15% of all intracranial vascular malformations [1-4]. 
Their aetiology is not fully understood; they are suspected 
to arise secondarily to inflammation or injury involving du-
ral sinus. Fistulas usually occur in the area of the transverse 
and sigmoid sinus, and the cavernous sinus.
Fistulas can remain asymptomatic until a patient reach-
es middle age or older. Patients may report symptoms from 
mild, such as headache, dizziness, and tinnitus, to serious 
neurological disorders, often resulting from bleeding. 
Symptoms are closely related to the type of outflow from 
the fistula and its location [4].
There are different classification systems, including the 
one proposed by Borden, subsequently extended by Cog-
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nard, based on the assessment of the risk of bleeding [5, 6]. 
Retrograde flow in the ectatic cortical vein is thought to 
be associated with the highest mortality and morbidity. 
These characteristics render prompt treatment: endovascu-
lar embolisation, surgical resection, or radiosurgery. Often, 
effective treatment is a combination thereof [4].
There are mixed reports on the incidence of intracra-
nial haemorrhage in patients with dural arteriovenous 
fistulas. We tried to further facilitate risk assessment by 
implementing additional measurable angiographic charac-
teristics of the fistula. Elaborating on the previous expe-
riences and literature, we evaluated whether the number 
of outflows or the outflow diameter might add to risk as-
sessment.
Material and methods
We retrospectively reviewed our patient database from 
January 2006 and December 2016 and identified 40 cas-
es of dural arteriovenous fistulas. Patients with carotid- 
cavernous fistulas were excluded from the study, which 
ultimately yielded 25 patients with 28 dural arteriovenous 
fistulas. All patients were diagnosed and treated using 
a GE Innova 4100 Angiograph (GE Healthcare, Chicago, 
IL, USA). 
Patient demographics and angiographic data were col-
lected from the records. Angioarchitectural data includ-
ed location, feeding arteries, number of outflows, biggest 
outflow diameter, Cognard classification type, treatment 
method, number of treatment sessions, volume of contrast 
media used, dose received by the patient, amount of time 
needed to treat, and outcome on DSA. The angiographic 
data were independently reviewed and evaluated by two 
experienced interventional neuroradiologists. 
Patients in our study were divided into two groups: 
1) with intracranial haemorrhage and 2) without. The di-
agnosis of intracranial bleeding was confirmed on a CT 
scan. Bleeding was attributed to dural arteriovenous fis-
tulas in all patients.
Embolisation procedures were performed under 
general anaesthesia. Patients were given either Ultravist 
300 (Bayer AG, Leverkusen, Germany) (before 2012) or 
Visipaque 320 (GE Healthcare, Chicago, IL, USA) con-
trast material (after 2012). Diagnostic cerebral arterial 
angiography was performed, including at least four ves-
sels, through transfemoral access. A guide catheter was 
navigated into the appropriate parent vessel, and then 
a compatible microcatheter with a microwire were ad-
vanced selectively into the branches as close to the fistula 
as possible, allowing an adequate distance for reflux of the 
embolic agent. Embolisation of the fistulas was performed 
with a mixture of Histoacryl with lipiodol (2 : 1) and/or 
ONYX-18. The end point of the embolisation was the an-
giographic obliteration of the fistula.
Statistical analysis was performed using Statistica soft-
ware (StatSoft, Inc., Tulsa, OK, USA). Descriptive statis-
tics of all variables were calculated. Normally distribut-
ed quantitative variables were compared using Student’s 
t-test between patients with and without intracranial 
haemorrhage; non-normally distributed categorical var-
iables were compared using the U-Mann Whitney test. 
Correlations between all variables were calculated using 
the Spearman Correlation Coefficient: patient demo-
graphics and angiographic data-included location, feed-
ing arteries, number of outflows, biggest outflow diameter, 
Cognard classification type, treatment method, number 
of treatment sessions, volume of contrast media used, 
dose received by the patient, amount of time needed to 
treat, and outcome on DSA. The statistical level of signifi-
cance was set at p = 0.05.
Results
Fourteen (56%) patients presented with intracerebral 
haemorrhage, headache was noted in five patients (20%), 
hypoesthesia in two patients (8%), hemiparesis in two pa-
tients (8%), blurred vision in one patient (4%), and epilep-
sy in one patient (4%). Seven patients (28%) had fistulas 
diagnosed during cerebral aneurysm work-up. Multiple 
dural fistulas occurred in three patients (12%). In five cas-
es there was association with head trauma (20%).
Most fistulas drained into the transverse-sigmoid si-
nus (14 fistulas – 50%), six (21.4%) into the straight sinus, 
five (17.8%) into the superior sagittal sinus, and one each 
(3.6%) into the ethmoidal, cavernous, and foramen mag-
num (Table 1).
Spearman’s rank correlation coefficient revealed sever-
al statistically significant correlations. There was a strong 
association between Cognard classification type and 
time needed to treat a fistula, expressed either in minutes 
or number of sessions (r = 0.59, p < 0.05 and r = 0.51, 
p < 0.05; respectively), unsurprisingly affecting also the 
volume of contrast used (r = 0.77, p < 0.05). It was more 
challenging to close a higher Cognard classification type 
fistula, although the coefficient did not reach statistical 
significance (r = –0.33, p > 0.05), especially those located 
infratentorially (r = 0.53, p < 0.05) and on the right side 
(r = 0.66, p < 0.05). 
Bleeding was associated with poorer clinical outcome 
as expressed by modified Rankin Scale score (r = 0.48, 
p < 0.05). Older patients tended to absorb significantly 
higher doses (r = 0.58, p < 0.05), which was associated 
with the time of the procedure (r = 0.67, p < 0.05)
Cognard classifications of all fistulas as well as other 
angiographic characteristics are presented in Table 1. We 
found no statistically significant differences between the 
non-haemorrhagic group and the haemorrhagic group 
regarding the age and sex of the patients (p = 0.106 and 
p = 0.54, respectively), location of the fistula (overall 
p = 0.86), number of outflows (p = 0.459), greatest outflow 
diameter (p = 0.298), Cognard classification type (overall 
p = 0.118), or procedure-related time and resources.
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Clinical evaluation at follow-up of all patients was ac-
cording to modified Rankin Scale (mRS). Fourteen (56%) 
patients were asymptomatic (score 0), six (24%) had 
non-significant or slight disability, maintaining independ-
ency, four (16%) had moderate disability, and two (8%) died, 
one in the course of intracerebral haemorrhage, and one due 
to other sustained injuries. Three (12%) patients were lost to 
follow-up. Clinical outcome on follow-up was significantly 
better for patients with no haemorrhage (p = 0.038). 
Overall, we achieved a 70% angiographic occlusion rate 
(via arterial feeders). We did not consider dAVFs down-
staged to type I in the course of treatment. There were no 
reported embolisation-related complications.
Discussion
Malik et al. [7] were among the first to identify cortical 
venous drainage as the main risk factor for haemorrhagic 
presentation of dural arteriovenous fistulas. Reported rates 
of haemorrhage and neurological symptoms not directly 
related to haemorrhage in patients with cortical venous 
drainage vary due to relatively small study groups. Intracra-
nial haemorrhage and neurological symptoms are reported 
to be 4.5-35% and 7.2-30% annually, respectively [1, 8-10].
More recently, Li et al. [11] evaluated clinical and angio-
graphic characteristics of dAVFs associated with haemor-
rhagic presentation in a larger and more homogenous 
cohort of 236 patients. They found additional associations 
between intracerebral bleeding and tobacco and alcohol 
use, which we believe most of us intuitively advise our 
patients against. They confirmed the risk of all the angio-
graphic patterns reported before. 
We ventured to further aid in assessing the risk of 
haemorrhage by counting the number of cortical venous 
outflows and measuring the degree of venous ectasia in all 
fistulas. We believed there would be a direct association 
of at least outflow diameter. Statistical analysis failed to 
recognise this association. Actually, mean outflow diam-
eter for the haemorrhagic group was smaller than for the 
non-haemorrhagic group (3.79 vs. 5.83 mm, respectively; 
p > 0.05). However, the relationship might be reversed 
in a larger cohort in long-term observation. Li et al. [11] 
looked at this problem from another perspective, evalu-
ating multiple arterial feeders as a potential risk factor of 
cerebral haemorrhage, and found the opposite (82.8% vs. 
67.9%, p = 0.016; for non-haemorrhagic and haemorrhag-
ic presentation, respectively).
Contrary to many reports on high association of cor-
tical venous ectasia with haemorrhage, in our study 63% 
of Cognard type IV fistulas had a non-haemorrhagic pres-
entation as compared to 20% of those classified as type I. 
Overall, intracerebral haemorrhage was diagnosed in 
eight type I fistulas (which account for 30.7% of all fis-
tulas) but only in four (15.2%) type IV fistulas. We be-
lieve the main reason is the inhomogeneity of our study 
group. One of the patients was diagnosed with a fistula in 
the course of diagnostic work-up of intracerebral haem-
orrhage after a severe motor vehicle accident, which was 
the direct cause of bleeding. On angiography, it was clas-
sified as type I, although it was of very high flow. We do 
not know if the patient developed the fistula after a head 
trauma and subsequently developed a substantial haemor-
rhage, or if the trauma led to disruption of a pre-existing 
fistula. The fistula was successfully closed with Onyx-18, 
but the patient died of other sustained injuries.
Post-traumatic dural arteriovenous fistulas represent 
a small proportion of all dural fistulas in scientific reports, 
mostly cases with no (to the best of our knowledge) cohort 
studies [12-14]. The majority of all reported cases of head 
trauma-related dAVFs are caroticocavernous fistulas, which 
have a distinct presentation and natural history [15]. There 
is an added value of traumatic injuries to the presence of 
fistula alone, which presumably accounts for higher mor-
tality and morbidity, especially in the scenario of intrac-
erebral bleeding; however, it is to be established in future 
studies.
Trauma-related dAVFs were not directly associated 
with the severity of recent injury, as presented by Fried-
Table 1. Angiographic characteristics of fistulas and differences between 
non-haemorrhagic and haemorrhagic groups. Statistical significance set at 
p < 0.05
Angiographic 
characteristic
Non-haemor rhagic Haemorrhagic p
Location
Transverse-sigmoid 7 (25.0%) 7 (25.0%) n/s
Straight 2 (7.1%) 4 (14.3%) n/s
Superior sagittal 3 (10.7%) 1 (3.6%) n/s
Ethmoidal 0 (0%) 1 (3.6%) n/s
Foramen magnum 0 (0%) 1 (3.6%) n/s
Cavernous 1 (3.6%) 0 (0%) n/s
Biggest outflow 
diameter (mean)
5.83 3.79 n/s
Cognard classification
I 2 (7.1%) 8 (28.6%) n/s
IIa + b 1 (3.6%) 0 (0%) n/s
III 3 (10.7%) 2 (7.1%) n/s
IV 8 (28.6%) 4 (14.3%) n/s
Median number 
of sessions
1 (1-5) 1 (1-5) n/s
Mean time  
of treatment |per 
session (min)
40 44.5 n/s
Mean volume 
of contrast used
per session (ml)
165 173 n/s
Mean absorbed dose 
per session (mGy)
1185 1394 n/s
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man et al. [16], who described a case of progressive, dis-
seminated, posttraumatic dural arteriovenous fistulas re-
sulting in the eventual death of the patient, after minimal 
head trauma (in contrast to our patient). A 31-year-old 
man was struck on the head while playing basketball. 
Two weeks later a soft, pulsatile mass developed on his 
vertex – a dural arteriovenous fistula. In this case, in the 
course of five years, multimodal therapy was unsuccess-
ful, the patient suffered from diffuse venous hypertension 
and fatal multiple intracerebral haemorrhages in both 
hemispheres.
Overall in our study group five patients had a history 
of head trauma, complicated by intracranial haemorrhage 
or tuberculous meningitis, all of which are risk factors for 
development of dAVFs. Most of these can be attributed to 
either vascular wall incompetency (posttraumatic or other) 
or hypercoagulable (even if local, and immune driven) 
states [4, 10-12].
Overall we achieved a 70% angiographic occlusion 
rate (via arterial feeders), which is comparable to those 
reported in literature, at 77-95% [17-20]. We used three 
different embolysates: histoacryl with lipiodol, Onyx-18, 
and most recently Phil. Although Onyx-18 is regarded as 
the go-to treatment for cerebral vascular malformations, 
we had three patients who received a mixed treatment 
with histoacryl followed by Onyx-18. In two of them 
> 80% of fistula volume was closed in multiple attempts, 
while final treatment was ceased due to difficulties in safe 
catherisation of the feeding arteries. The preference of 
choosing different agents was based on its availability at 
the time, with Onyx replacing histoacryl in recent years.
Initial and durable angiographic occlusion rates for 
embolisation of intracranial dural arteriovenous fistulas 
are reported to be significantly high for ONYX-18 com-
pared with histoacryl [17-20]. Choo and Shankar [18] 
found that the chance of not requiring post-embolisation 
surgery with Onyx-18 was significantly higher than with 
histoacryl (81.8% vs. 22.2%, respectively). Moreover, pa-
tients treated with Onyx-18 tended to have lower compli-
cation rates compared with that of histoacryl. There are 
initial but promising reports regarding Phil, and its safety 
and efficacy is yet to be evaluated in future studies [21]. 
We utilised it in one case of a type I fistula and achieved 
closure on angiography (Figure 1).
Initial angiographic success may not necessarily lead 
to long-term cure. Abekar et al. [22] followed 21 patients 
on angiography after a mean of 14 months post treatment 
(range 2-39 months). Asymptomatic angiographic recur-
rence of the fistula was evident in 14.3% of patients. On 
reviewing the procedural angiograms there was incomplete 
penetration of the embolic material into the venous portion 
of the fistula. In a much larger cohort, Gross et al. [2] re-
ported that recurrence or occult residual lesions were seen 
on subsequent angiography in 3% of cases. In our experi-
ence, we had no actual recurrent fistulas; however, we saw 
partial histoacryl resorption, which may eventually lead 
to relapse of the fistula. Moreover, one of our patients with 
type IV fistula, with mild neurological symptoms, initially 
treated endovascularly, and with most of the fistula volume 
closed, was lost to follow-up. After two years he was read-
mitted with subarachnoid haemorrhage attributable to the 
already progressed fistula (Figure 2).
At our institution, we perform treatment for sympto-
matic dural arteriovenous fistulas regardless of type, aim-
ing at initial closure if possible, because the natural history 
of the lesion may depend on the type of presentation and 
not necessarily its morphology [1, 4, 7, 10, 11]. Strom et al. 
[23] reported that asymptomatic compared to symptomat-
ic fistulas have annual haemorrhage rates of 1.4% versus 
19%, respectively. Nevertheless, lower annual haemorrhage 
A B
Figure 1. Patient with type I fistula (black arrow), presenting as subarachnoid haemorrhage with intraventricular bleeding. Angiographic closure was 
achieved with PHIL (note the absence of feeding artery – white arrows). On follow-up, there was left abducens nerve palsy
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rates of asymptomatic dural arteriovenous fistulas (type II 
and III) [1, 4, 7, 10, 11] still pose significant long-term risk 
to patients. In our experience every fistula poses a significant 
risk of haemorrhage. In our study type I fistulas accounted 
for more haemorrhagic presentations that type III and IV 
combined. There is an additional risk involving the pres-
ence of type I fistula because it usually presents itself only 
due to haemorrhage, remaining unnoticed until that time. 
It could be the case with posttraumatic fistulas – most of 
them probably remain undiagnosed when involving drain-
ing structures other than the lateral or cavernous sinuses, 
or unless they bleed. 
For asymptomatic patients, we propose justifiable elec-
tive treatment if the patient consents to the procedure, 
after evaluating the anatomy and individual risk of bleed-
ing. Regardless of initial angiographic results or treat-
ment options, long-term angiographic follow-up is highly 
recom mended for all patients [2, 22, 23].
Spontaneous closure of the dural arteriovenous fis-
tula is rare. Most of the cases involve posttraumatic le-
sions, which tend to be single, small, type I lesions, often 
asymptomatic, and remaining unnoticed [24]. Posttrau-
matic vessel damage could lead to development of scar 
tissue during the healing process, thus leading to sec-
ondary occlusion of the fistula itself. The other mecha-
nism of spontaneous dAVF closure would be intracrani-
al haemorrhage – for non-posttraumatic fistulas. Some 
authors claimed intracranial haemorrhage could trigger 
the closure of intracranial arteriovenous malformations, 
fistulas included, whether linked to haematoma-mediated 
mass effect or to the secondary vasospasm of the feeding 
arteries [24, 25].
Our study has some limitations. We presented our ex-
perience and results of treatment of a relatively small group 
of patients with intracranial dural arteriovenous fistulas. 
Our study did not identify a new risk factor of intracranial 
A
C
B
Figure 2. One of our patients with type IV fistula, with mild neurological 
symptoms, initially treated endovascularly, with most of the fistula volume 
closed, was lost to follow-up. After two years he was readmitted with sub-
arachnoid haemorrhage attributable to the already progressed fistula
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haemorrhage in intracranial dAVFs, nor did it confirm 
the previously reported risk factors, probably due to some 
inhomogeneity in a small population. Nevertheless, we 
believe our proposition might still be of use if a greater 
population-based cohort were to be analysed. Moreover, 
our study showed that we should not underestimate the 
potential risk of complications of lower type fistulas.
To conclude, regardless of presentation, both symp-
tomatic and asymptomatic dural arteriovenous fistulas 
deserve clinical attention, structured evaluation, and fol-
low-up. Type I fistulas were associated with haemorrhage 
in 1/3 of all cases. Overall our results indicate that the risk 
of haemorrhage and dire consequences is multifactorial.
Conclusions
To conclude, regardless of presentation, both symp-
tomatic and asymptomatic dural arteriovenous fistulas 
deserve clinical attention, structured evaluation, and 
follow-up. Type I fistulas were associated with haemor-
rhage in 1/3 of all cases. Overall our results indicate that 
the risk of haemorrhage and dire consequences is multi-
factorial.
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